오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - amitriptyline hydrochloride -

미국 - 영어 - NLM (National Library of Medicine)

direct rx - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - amitriptyline hydrochloride 10 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with a gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infa

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; macrogol 6000; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; crospovidone; titanium dioxide; maize starch; purified talc; sunset yellow fcf aluminium lake; hypromellose; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; microcrystalline cellulose; brilliant blue fcf aluminium lake; titanium dioxide; macrogol 6000; magnesium stearate; purified talc; hypromellose; maize starch; crospovidone - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; purified talc; colloidal anhydrous silica; crospovidone; lactose monohydrate; quinoline yellow aluminium lake; titanium dioxide; macrogol 6000; maize starch - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.